Design of a self-driven probiotic-crispr/cas9 nanosystem for sono-immunometabolic cancer therapy

HIGHLIGHTS

• who: Jifeng Yu from the (DPBF) was gained from Sigma-Aldrich CoLtd., USA have published the research work: Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy, in the Journal: (JOURNAL) of 28/01/2022
• what: Another US-imposed experiment was carried out to assess the biosafety of LGG-MHS under the authors stimulation. In contrast to traditional strategies of overcoming hypoxia, this research exploited the hypoxic microenvironment of tumors and utilized the hypoxia-driven and colonization properties of LGG as a vector for delivery of the CRISPR/Cas9 nanosystem . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.